Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 1/20 | 0.42 |
| ▸ | ATP4A | P20648 | 2/20 | 0.41 |
| ▸ | ATP4B | P51164 | 2/20 | 0.41 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 3/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | DHPS | P49366 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13062428 | 0.90 | ADORA3 (0.40) | ADORA3ADORA1ADORA2AHTR6ATP4A | |
| SCHEMBL3783003 | 0.84 | ATP4A (0.36) | ADORA3ADORA1ADORA2AHTR6ATP4A | |
| SCHEMBL3777175 | 0.84 | ATP4A (0.39) | ADORA3ADORA1ADORA2AHTR6ATP4A | |
| SCHEMBL3739891 | 0.83 | ADORA2A (0.36) | ADORA3ADORA1ADORA2AHTR6IDO1 | |
| SCHEMBL3775535 | 0.83 | ALDH1A1 (0.43) | ADORA3ADORA1ADORA2AHTR6ATP4A | |
| SCHEMBL4217671 | 0.83 | ADORA3 (0.35) | ADORA3ADORA1ADORA2AHTR6IDO1 | |
| SCHEMBL2289349 | 0.83 | HTR6 (0.38) | ADORA3ADORA1ADORA2AHTR6IDO1 | |
| SCHEMBL2286796 | 0.83 | HTR6 (0.38) | ADORA3ADORA1ADORA2AHTR6IDO1 | |
| SCHEMBL2283485 | 0.74 | BACE1 (0.32) | ADORA3ADORA1ADORA2AHTR6MAPK1 | |
| SCHEMBL2287061 | 0.74 | GAA (0.35) | ADORA3ADORA1ADORA2AHTR6DHPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100323896-A1 | USE OF SULFONANILIDES AS HERBICIDE | BAYER CROPSCIENCE AG (DE) | 2010-12-23 | — | — | US | disclosed |
| US-20100323896-A1 | USE OF SULFONANILIDES AS HERBICIDE | BAYER CROPSCIENCE AG (DE) | 2010-12-23 | — | — | US | disclosed |
| US-20090305894-A1 | use of sulfonanilides as herbicide | BAYER CROPSCIENCE AG (DE) | 2009-12-10 | — | — | US | disclosed |
| US-20090305894-A1 | use of sulfonanilides as herbicide | BAYER CROPSCIENCE AG (DE) | 2009-12-10 | — | — | US | disclosed |
| EP-1928242-A2 | A USE OF SULFONANILIDES AS HERBICIDE | Bayer CropScience AG (DE) | 2008-06-11 | — | — | EP | disclosed |
| WO-2007031208-A2 | A USE OF SULFONANILIDES AS HERBICIDE | BAYER CROPSCIENCE AG (DE) | 2007-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100323896-A1 | USE OF SULFONANILIDES AS HERBICIDE | CBR3, HCAR3, HCRTR1 | ADORA3 931/4885ADORA1 2200/4885ADORA2A 3496/4885 |
| US-20090305894-A1 | use of sulfonanilides as herbicide | CBR3, HCAR3, CBR1 | ADORA3 913/4885ADORA1 2191/4885ADORA2A 3463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.